Key result
Bacterial infection in children is linked to elevated serum MYBPHL versus healthy controls.
Why the study?
Does DNA methylation-regulated MYBPHL expression associate with and protect against LPS-induced septic myocardial injury in children with bacterial infection and mouse cardiomyocytes?
Cohort (n=49)
Does DNA methylation-regulated MYBPHL expression associate with and protect against LPS-induced septic myocardial injury in children with bacterial infection and mouse cardiomyocytes?
MYBPHL expression is elevated in pediatric bacterial infection and appears to exert a protective, compensatory effect against LPS-induced myocardial injury via regulation by DNA methylation enzymes DNMT3A and TET1.
Answers are grounded in this paper and cite their sources.
MYBPHL expression may associate with pediatric septic myocardial injury; leaves open biomarker or therapeutic roles pending validation.
Septic myocardial injury is a major complication of bacterial infection in children, and effective early biomarkers and therapeutic targets remain insufficiently defined. Studies have shown that Myosin-binding protein H-like (MYBPHL) plays a crucial role in the maintenance of normal cardiac function. This study aimed to explore the association between MYBPHL expression, DNA methylation-related enzymes, and myocardial injury caused by bacterial infection, and to investigate the potential protective role of MYBPHL in an in vitro model. This study combined a clinical cohort with in vitro experiments. (1) Serum samples were collected from 27 children with bacterial infection and 22 age- and sex-matched healthy controls. Levels of LPS, MYBPHL, DNMT1, DNMT3A, BNP, and cTn-I were measured by ELISA. Patient demographics, clinical severity indicators (C-reactive protein, white blood cell count), and septic myocardial injury markers were recorded. (2) Mouse cardiomyocyte (MCM) cells were treated with lipopolysaccharide (LPS, 10 µg/mL, 24 h) to establish an in vitro model of LPS-induced myocardial injury. Expression of DNMT3A, TET1, and MYBPHL was manipulated by overexpression vectors or short hairpin RNA (shRNA) and assessed by RT-qPCR and Western blotting. Cell apoptosis was quantified by flow cytometry (Annexin V-FITC/PI staining) and cTn-I secretion by ELISA. (1) Compared with healthy controls, serum LPS (572.5 ± 41.44 vs. 536.4 ± 55.47 ng/mL), MYBPHL (1445 ± 105.8 vs. 1383 ± 107.1 ng/L), BNP (229.7 ± 19.9 vs. 219.3 ± 12.4 pg/mL), and cTn-I (398.7 ± 27.7 vs. 377.2 ± 33.18 ng/L) were significantly elevated in children with bacterial infection (all P < 0.05), while DNMT3A was significantly decreased (164.7 ± 11.36 vs. 173.8 ± 11.6 pg/mL; P < 0.01); DNMT1 showed no significant difference (915.1 ± 79.14 vs. 917.8 ± 78.16 pg/mL; P = 0.9045). These findings suggest a clinically relevant association between reduced DNMT3A, elevated MYBPHL, and septic myocardial injury. (2) In MCM cells, LPS treatment reduced DNMT3A and DNMT3B expression and increased TET1 expression, changes consistent with a net reduction in DNA methylation, and promoted cardiomyocyte apoptosis ( P < 0.05). Conversely, increasing DNA methylation potential via DNMT3A overexpression or TET1 knockdown suppressed MYBPHL expression and exacerbated LPS-induced myocardial injury. This injury was partially rescued by MYBPHL re-expression. MYBPHL may exert a compensatory, protective response against septic myocardial injury. Its expression is associated with and may be negatively regulated by the DNA methylation machinery, primarily through DNMT3A and TET1. MYBPHL represents a potential candidate biomarker and therapeutic target for septic myocardial injury in children. Future studies employing animal models and genome-wide bisulfite sequencing are warranted to confirm whether direct methylation of the MYBPHL promoter occurs and to extend these findings in vivo.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) conducted a cohort in Septic myocardial injury / bacterial infection in children (n=49). Bacterial infection / LPS-induced myocardial injury vs. Age- and sex-matched healthy controls was evaluated on Serum MYBPHL concentration (ng/L) (p=<0.05). Bacterial infection in children was associated with elevated serum MYBPHL and reduced DNMT3A versus healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: